Needle-X: Usability Testing of a Smartphone Application
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03665298|
Recruitment Status : Not yet recruiting
First Posted : September 11, 2018
Last Update Posted : January 4, 2019
|Condition or disease||Intervention/treatment||Phase|
|Opioid Dependence||Behavioral: Smartphone Application||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||65 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Needle-X: Usability Testing of a Smartphone Application|
|Estimated Study Start Date :||February 2019|
|Estimated Primary Completion Date :||November 2019|
|Estimated Study Completion Date :||November 2019|
Experimental: Needle X
Smartphone application application to enhance access to sterile needles, naloxone overdose kits, and addiction treatment programs in New York City.
Behavioral: Smartphone Application
App that helps patients find syringe exchange programs, safe way to dispose of needles, access to naloxone kits and access to free medical care and addiction treatment programs.
- Feasibility of Needle-X application [ Time Frame: 12 Months ]number of patients enrolled, as this study will include a single interaction, at which point the patient will no longer be part of the study.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03665298
|Contact: Chemi Chemi||646 501 7743||Chemi.Chemi@nyumc.org|
|United States, New York|
|New York University School of Medicine||Not yet recruiting|
|New York, New York, United States, 10016|
|Contact: Chemi Chemi 646-501-7743 firstname.lastname@example.org|
|Principal Investigator: Babak Tofighi, MD|
|Principal Investigator:||Babak Tofighi, MD||NYU Langone Health|